Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Hess, V; Pratsch, S; Potthast, S; Lee, L; Winterhalder, R; Widmer, L; Cescato, C; Lohri, A; Jost, L; Stillhart, P; Pestalozzi, B; Herrmann, R (2010). Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Annals of Oncology, 21(12):2390-2395.

Ruhstaller, T; Widmer, L; Schuller, J C; Roth, A; Hess, V; Mingrone, W; von Moos, R; Borner, M; Pestalozzi, B C; BalmerMajno, S; Koberle, D; Terraciano, L; Schnider, A; Bodis, S; Popescu, R; Swiss Group for Clinical Cancer Research (SAKK) (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of Oncology, 20(9):1522-1528.

D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4):739-745.

Pichert, G; Schmitter, D; Widmer, L; Jost, L M; Kurrer, M O; Maurer, R; Stahel, R A (1998). Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas. Annals of Oncology, 9(1):51-54.

Jost, L M; Widmer, L; Honegger, H P; Stahel, R A (1997). Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease. Annals of Oncology, 8(8):785-790.

This list was generated on Mon Dec 10 10:14:40 2018 CET.